A new optionCheck my knee

ARC Library

Peripheral Nerve Stimulation for Head and Neck Pain

How PNS is applied to chronic cervicogenic headache, occipital neuralgia, and neck pain — the nerves involved and what evidence shows.

Category: Deep dive3 min read

Chronic head and neck pain: a distinct challenge

Head and neck pain occupies a unique clinical space. Unlike joint pain at the knee or shoulder — where the pain source and treatment target are relatively discrete — head and neck pain often involves complex, overlapping nerve territories, referred pain patterns, and significant central nervous system involvement.

Conditions including chronic cervicogenic headache (headache originating from cervical spine structures), occipital neuralgia (pain in the distribution of the occipital nerves), chronic neck pain from facet joint pathology, and persistent post-surgical head and neck pain represent a patient population with limited effective treatment options. Peripheral nerve stimulation has emerged as a relevant option for carefully selected patients in this group.

The occipital nerves and their role in head pain

The occipital nerves — the greater, lesser, and third occipital nerves — supply sensory input to the posterior scalp and upper neck. In occipital neuralgia, these nerves are involved in pain that typically manifests as severe, lancinating pain starting at the base of the skull and radiating over the scalp.

Traditional management includes occipital nerve blocks (corticosteroid and local anesthetic injections) and oral medications. Peripheral nerve stimulation targeting the occipital nerves has been studied for patients who respond to occipital nerve blocks but don't maintain lasting relief from injections alone — using the positive response to injection as a predictor of PNS responsiveness.

Cervicogenic headache and cervical nerves

Cervicogenic headache is defined as headache secondary to cervical spine pathology. Pain originates from structures in the neck — most commonly the upper cervical facet joints, intervertebral discs, or cervical musculature — and refers to the head. It typically presents on one side, often originating in the neck and radiating to the frontal or orbital region.

PNS for cervicogenic headache targets the medial branch nerves supplying the upper cervical facet joints, or other peripheral sensory nerves involved in the pain pathway. As with occipital neuralgia, a positive response to diagnostic nerve blocks informs candidacy for stimulation in this population.

Clinical evidence for head and neck PNS

Peripheral nerve stimulation for occipital neuralgia and cervicogenic headache has been studied in case series and prospective studies with generally positive results. Patients with refractory occipital neuralgia who failed prior conservative management have demonstrated significant pain reduction and improvement in quality of life in multiple published reports.

For cervicogenic headache, the evidence base is less mature but growing. Emerging studies suggest PNS can provide meaningful relief for patients in whom the pain generator has been clearly identified through diagnostic blocks and who have not responded adequately to injection therapy alone. Careful patient selection, guided by diagnostic workup, is essential to optimizing outcomes in this population.

Procedural approach for head and neck targets

PNS for head and neck pain follows the same general outpatient framework as other PNS procedures. Leads are placed near the targeted nerves — typically at the occipital notch for occipital nerve stimulation, or near upper cervical bony landmarks for medial branch targets — using imaging guidance.

Because these procedures are adjacent to sensitive structures, physician experience and imaging accuracy are particularly important. The procedure is performed under local anesthesia with the patient awake, allowing sensory confirmation of correct lead position. Most patients experience minimal procedure-related discomfort and return home the same day.

Candidacy and realistic expectations

The strongest candidates for head and neck PNS are patients with clearly localized, documented nerve-mediated pain — those who have had a positive diagnostic response to nerve blocks targeting the same nerves, who have failed conventional management, and who have realistic expectations about the goals of treatment.

PNS in this context is not a cure and should not be framed as one. It is a pain management intervention. For patients whose pain is meaningfully reducing their quality of life and who have not found lasting relief through prior treatments, it represents a clinically supported option that should be evaluated with a physician experienced in head and neck pain management.

Common questions

Which conditions is head and neck PNS used for?
Chronic cervicogenic headache, occipital neuralgia, chronic neck pain from facet joint pathology, and persistent post-surgical head and neck pain — a population with limited effective options in conventional management.
Which nerves are involved in occipital neuralgia?
The greater, lesser and third occipital nerves, which supply sensory input to the posterior scalp and upper neck. Pain typically presents as severe, lancinating pain starting at the base of the skull and radiating over the scalp.
How do physicians decide whether I am likely to respond?
A positive response to a diagnostic nerve block targeting the same nerves is the usual signal. Stimulation is studied mainly in people who respond to those blocks but do not maintain lasting relief from injections alone.
Is it a cure?
No, and it should not be framed as one. It is a pain management intervention, and careful selection guided by diagnostic workup is what makes the difference to outcomes in this group.

Keep reading

Related articles

Next step

You have read it. Now find out whether it applies to you.

An assessment is a conversation with a specialist, not a commitment. Asking commits you to nothing and schedules nothing.

Coverage and what ARC is

Whether your plan covers the procedure is a question for your plan and for the location, and it is worth asking both. Plans that cover peripheral nerve stimulation do so against their own criteria, and those criteria differ from plan to plan. ARC does not bill, does not verify benefits, and cannot promise what a plan will pay. ARC Joint is not a healthcare provider: it does not treat, schedule or bill, and it does not own the practices. Nothing here is a diagnosis or a promise of a result.